Received: 10 November 2016
Accepted: 20 May 2017
First Online: 17 July 2017
Change Date: 14 July 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/S41593-020-0681-Z
: S.W.S., M.U. and the Hospital for Sick Children hold intellectual property used in this analysis, which is also licensed by Lineagen, Inc. M.P. has received educational honoraria from Otsuka, research grants from Fundación Alicia Koplowitz and Mutua Madrileña and travel grants from Otsuka and Janssen. C.A. has been a consultant to or has received honoraria or grants from Abbot, Amgen, AstraZeneca, Bristol-Myers-Squibb, Caja Navarra, CIBERSAM, Fundación Alicia Koplowitz, Instituto de Salud Carlos III, Janssen Cilag, Lundbeck, Merck, Ministerio de Ciencia e Innovación, Ministerio de Sanidad, Ministerio de Economía y Competitividad, Mutua Madrileña, Otsuka, Pfizer, Roche, Servier, Shire, Takeda and Schering-Plough.